Jolien Ceusters

574 total citations
19 papers, 248 citations indexed

About

Jolien Ceusters is a scholar working on Immunology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Jolien Ceusters has authored 19 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Obstetrics and Gynecology and 8 papers in Reproductive Medicine. Recurrent topics in Jolien Ceusters's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Immune cells in cancer (5 papers). Jolien Ceusters is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Immune cells in cancer (5 papers). Jolien Ceusters collaborates with scholars based in Belgium, United Kingdom and Italy. Jolien Ceusters's co-authors include An Coosemans, Patrizia Agostinis, Abhishek D. Garg, Lorenzo Galluzzi, Jenny Sprooten, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Ignace Vergote and Thaïs Baert and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Frontiers in Immunology and BMC Medical Research Methodology.

In The Last Decade

Jolien Ceusters

18 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jolien Ceusters Belgium 7 161 109 67 48 23 19 248
Kassondra Meyer United States 9 96 0.6× 269 2.5× 123 1.8× 128 2.7× 15 0.7× 14 355
Maud Jonnaert United States 6 146 0.9× 99 0.9× 122 1.8× 88 1.8× 14 0.6× 8 321
Jessica Mariel Sierra Argentina 7 192 1.2× 125 1.1× 35 0.5× 27 0.6× 6 0.3× 10 276
Laura Santana González United States 4 43 0.3× 65 0.6× 105 1.6× 52 1.1× 12 0.5× 7 207
Jossie Rotman Netherlands 10 145 0.9× 188 1.7× 91 1.4× 10 0.2× 17 0.7× 10 324
Heather Derocher Canada 6 196 1.2× 288 2.6× 65 1.0× 50 1.0× 41 1.8× 6 406
Baohui Ju China 6 119 0.7× 39 0.4× 95 1.4× 56 1.2× 9 0.4× 9 276
Megan Wachsmann United States 7 73 0.5× 167 1.5× 79 1.2× 10 0.2× 13 0.6× 11 273
Miseon Lee South Korea 7 172 1.1× 230 2.1× 51 0.8× 10 0.2× 7 0.3× 19 297
Daniel J. Craig United States 8 51 0.3× 96 0.9× 51 0.8× 8 0.2× 15 0.7× 13 191

Countries citing papers authored by Jolien Ceusters

Since Specialization
Citations

This map shows the geographic impact of Jolien Ceusters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolien Ceusters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolien Ceusters more than expected).

Fields of papers citing papers by Jolien Ceusters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolien Ceusters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolien Ceusters. The network helps show where Jolien Ceusters may publish in the future.

Co-authorship network of co-authors of Jolien Ceusters

This figure shows the co-authorship network connecting the top 25 collaborators of Jolien Ceusters. A scholar is included among the top collaborators of Jolien Ceusters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolien Ceusters. Jolien Ceusters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Moro, F., Jolien Ceusters, F. Mascilini, et al.. (2025). External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6). American Journal of Obstetrics and Gynecology. 233(6). 629.e1–629.e13. 1 indexed citations
2.
3.
Ceusters, Jolien, et al.. (2024). TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice. Cancers. 16(6). 1147–1147. 1 indexed citations
4.
Pascual, M., Jolien Ceusters, Alison Ledger, et al.. (2024). Validation of ADNEX and IOTA two‐step strategy and estimation of risk of complications during follow‐up of adnexal masses in low‐risk population. Ultrasound in Obstetrics and Gynecology. 64(3). 395–404. 3 indexed citations
5.
Ceusters, Jolien, et al.. (2023). Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy. Frontiers in Immunology. 14. 1236965–1236965. 5 indexed citations
6.
Ceusters, Jolien, L. Valentin, A. C. Testa, et al.. (2023). Multiclass risk models for ovarian malignancy: an illustration of prediction uncertainty due to the choice of algorithm. BMC Medical Research Methodology. 23(1). 276–276. 4 indexed citations
7.
Bruyn, C. De, Jolien Ceusters, Wouter Froyman, et al.. (2023). Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study. Ultrasound in Obstetrics and Gynecology. 63(5). 683–690. 6 indexed citations
8.
Ceusters, Jolien, Sandra Claes, Dominique Schols, et al.. (2022). Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model. Pharmaceutics. 14(4). 687–687. 5 indexed citations
9.
10.
Riva, Mattéo, David Nittner, Jolien Ceusters, et al.. (2022). Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas. Journal of Neurosurgical Sciences. 67(1). 55–65. 6 indexed citations
11.
Ceusters, Jolien, et al.. (2022). Do autoimmune diseases influence the onset and progression of ovarian cancer? A systematic review and meta-analysis. International Journal of Gynecological Cancer. 32(12). 1583–1591. 3 indexed citations
12.
Riva, Mattéo, et al.. (2022). Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model. Frontiers in Medicine. 9. 995325–995325. 2 indexed citations
13.
Bruyn, C. De, Jolien Ceusters, C. Landolfo, et al.. (2021). Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer. Cancers. 13(23). 5899–5899. 9 indexed citations
14.
Baert, Thaïs, Mattéo Riva, C. De Bruyn, et al.. (2021). Type of chemotherapy has substantial effects on the immune system in ovarian cancer. Translational Oncology. 14(6). 101076–101076. 15 indexed citations
15.
Landolfo, C., Erik Achten, Jolien Ceusters, et al.. (2020). Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors. Gynecologic Oncology. 159(3). 811–819. 9 indexed citations
16.
Mathivet, Thomas, Jolien Ceusters, Thaïs Baert, et al.. (2020). Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study. Cells. 9(2). 305–305. 28 indexed citations
17.
Coosemans, An, Thaïs Baert, Anaïs Van Hoylandt, et al.. (2019). Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer. Anticancer Research. 39(11). 5953–5962. 15 indexed citations
18.
Coosemans, An, Thaïs Baert, Jolien Ceusters, et al.. (2019). Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors. International Journal of Gynecological Cancer. 29(9). 1381–1388. 18 indexed citations
19.
Sprooten, Jenny, Jolien Ceusters, An Coosemans, et al.. (2019). Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology. 8(11). 1638212–1638212. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kassondra Meyer Breakdown of academic impact, for papers by Maud Jonnaert Breakdown of academic impact, for papers by Jessica Mariel Sierra Breakdown of academic impact, for papers by Laura Santana González Breakdown of academic impact, for papers by Jossie Rotman Breakdown of academic impact, for papers by Heather Derocher Breakdown of academic impact, for papers by Baohui Ju Breakdown of academic impact, for papers by Megan Wachsmann Breakdown of academic impact, for papers by Miseon Lee Breakdown of academic impact, for papers by Daniel J. Craig
Rankless by CCL
2026